Add Yahoo as a preferred source to see more of our stories on Google. Improvements testing models and the understanding of Parkinson's disease will help guide future drug development in the indication ...

The gut microbiome is a ripe target for future treatments that could potentially stop or slow PD progression at an early ...

Up to 1 in 3 people with Parkinson's disease use at least one psychotropic medication, a recent study from the University of ...

Go with your gut. Researchers at University College London have isolated a “microbial signature” in the gut that could help ...

New research suggests gut bacteria differences could signal Parkinson's disease risk years before symptoms emerge, according ...

For many individuals living with Parkinson's disease and those in its "prodromal" or early stages before movement impairment, ...

Returning or worsening Parkinson’s symptoms may indicate that your current medication isn’t working as well, signaling a need to consider switching or adjusting your treatment plan. In advanced stages ...

Q: A few years ago, you mentioned a study on the idea that GLP-1 drugs might have a protective effect for people with ...

Preclinical and clinical research focused on Parkinson’s disease has reached a “pivotal point”, but funding barriers and outdated clinical trial approaches remain critical barriers to innovation, says ...